These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9542916)

  • 21. In vitro antiviral efficacy of the ganciclovir complexed with beta-cyclodextrin on human cytomegalovirus clinical strains.
    Nicolazzi C; Venard V; Le Faou A; Finance C
    Antiviral Res; 2002 May; 54(2):121-7. PubMed ID: 12062397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New reporter cell line to evaluate the sequential emergence of multiple human cytomegalovirus mutations during in vitro drug exposure.
    Gilbert C; Boivin G
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4860-6. PubMed ID: 16304146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective inhibition of cytomegaloviruses by 9-(3'-ethylphosphono-1'-hydroxymethyl-1'-propyloxy-methyl)g uanine.
    Barnard DL; Huffman JH; Sidwell RW; Reist EJ
    Antiviral Res; 1993 Sep; 22(1):77-89. PubMed ID: 8250544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonnucleoside pyrrolopyrimidines with a unique mechanism of action against human cytomegalovirus.
    Jacobson JG; Renau TE; Nassiri MR; Sweier DG; Breitenbach JM; Townsend LB; Drach JC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1888-94. PubMed ID: 10428908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.
    Herget T; Freitag M; Morbitzer M; Kupfer R; Stamminger T; Marschall M
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4154-62. PubMed ID: 15504835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral activity of ganciclovir and artesunate towards human cytomegalovirus in astrocytoma cells.
    Schnepf N; Corvo J; Pors MJ; Mazeron MC
    Antiviral Res; 2011 Feb; 89(2):186-8. PubMed ID: 21167209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir.
    Stanat SC; Reardon JE; Erice A; Jordan MC; Drew WL; Biron KK
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2191-7. PubMed ID: 1666492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid detection of cytomegalovirus strains resistant to ganciclovir through mutations within the gene UL97.
    Alain S; Mazeron MC; Pépin JM; Morinet F; Raskine L; Sanson-Le Pors MJ
    Mol Cell Probes; 1993 Dec; 7(6):487-95. PubMed ID: 8145779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ganciclovir susceptibilities of cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis.
    Boivin G; Erice A; Crane DD; Dunn DL; Balfour HH
    J Infect Dis; 1993 Aug; 168(2):332-5. PubMed ID: 8393055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (1110U81) potently inhibits human cytomegalovirus replication and potentiates the antiviral effects of ganciclovir.
    Hamzeh FM; Spector T; Lietman PS
    Antimicrob Agents Chemother; 1993 Mar; 37(3):602-4. PubMed ID: 8384821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid antiviral DNA-DNA hybridization assay for human cytomegalovirus.
    Dankner WM; Scholl D; Stanat SC; Martin M; Sonke RL; Spector SA
    J Virol Methods; 1990 Jun; 28(3):293-8. PubMed ID: 2166749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of human cytomegalovirus in culture by alkenyl guanine analogs of the thiazolo[4,5-d]pyrimidine ring system.
    Lewis AF; Drach JC; Fennewald SM; Huffman JH; Ptak RG; Sommadossi JP; Revankar GR; Rando RF
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2889-95. PubMed ID: 7695278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus.
    Posthuma CC; van der Beek MT; van der Blij-de Brouwer CS; van der Heiden PL; Marijt EW; Spaan WJ; Claas EC; Nederstigt C; Vossen AC; Snijder EJ; Kroes AC
    J Clin Virol; 2011 May; 51(1):25-30. PubMed ID: 21388868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol) are active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants.
    Baldanti F; Sarasini A; Drach JC; Zemlicka J; Gerna G
    Antiviral Res; 2002 Dec; 56(3):273-8. PubMed ID: 12406510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.
    Landry ML; Stanat S; Biron K; Brambilla D; Britt W; Jokela J; Chou S; Drew WL; Erice A; Gilliam B; Lurain N; Manischewitz J; Miner R; Nokta M; Reichelderfer P; Spector S; Weinberg A; Yen-Lieberman B; Crumpacker C
    Antimicrob Agents Chemother; 2000 Mar; 44(3):688-92. PubMed ID: 10681339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of allitridin on transcription of immediate-early, early and late genes of human cytomegalovirus in vitro].
    Zhang J; Xiang Z; Liu X; Wang H; Li G; Fang F
    Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(14):1988-92. PubMed ID: 22016974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia.
    Gerna G; Zipeto D; Parea M; Percivalle E; Zavattoni M; Gaballo A; Milanesi G
    Mol Cell Probes; 1991 Oct; 5(5):365-74. PubMed ID: 1665208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins demonstrate a broad anti-cytomegalovirus activity in vitro in ganciclovir-susceptible and resistant strains.
    Ponroy N; Taveira A; Mueller NJ; Millard AL
    J Med Virol; 2015 Jan; 87(1):141-53. PubMed ID: 24976258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro susceptibility to ganciclovir and foscarnet of cytomegaloviruses].
    Otegui M; Rabella N; Labeaga R; Herrero M; Margall R; Muñoz JM; Prats G
    Rev Esp Quimioter; 2001 Jun; 14(2):155-64. PubMed ID: 11704769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS.
    Baldanti F; Underwood MR; Stanat SC; Biron KK; Chou S; Sarasini A; Silini E; Gerna G
    J Virol; 1996 Mar; 70(3):1390-5. PubMed ID: 8627655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.